BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19284622)

  • 1. Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.
    Jangro WC; Preval H; Southard R; Klotz SG; Francis A
    Child Adolesc Psychiatry Ment Health; 2009 Mar; 3(1):9. PubMed ID: 19284622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
    Mendelowitz AJ
    Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.
    Martel ML; Driver BE; Miner JR; Biros MH; Cole JB
    Acad Emerg Med; 2021 Apr; 28(4):421-434. PubMed ID: 32888340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.
    Preval H; Klotz SG; Southard R; Francis A
    Gen Hosp Psychiatry; 2005; 27(2):140-4. PubMed ID: 15763126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best clinical practice with ziprasidone IM: update after 2 years of experience.
    Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
    CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of acute agitation.
    Battaglia J
    Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-Generation Parenteral Antipsychotic (Olanzapine) as a First-Line Treatment for Acute Undifferentiated Agitation in the Emergency Department in Comparison With Haloperidol.
    Singh AP; Murali Mohan NT
    Cureus; 2023 Jun; 15(6):e40226. PubMed ID: 37435257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
    Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
    Zhang H; Wang G; Zhao J; Xie S; Xu X; Shi J; Deng H; Li K; Gao C; Wang X; Vanderburg D; Pan S; Tang H; Shu L; Karayal ON
    J Clin Psychopharmacol; 2013 Apr; 33(2):178-85. PubMed ID: 23422376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
    Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
    J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW; Simpson GM
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
    Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
    Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol Versus Ziprasidone With Concomitant Medications and Other Predictors of Physical Restraint Duration in the Emergency Department.
    Coralic Z; Rader ES; Vinson DR; Wilson MP
    J Emerg Med; 2022 May; 62(5):636-647. PubMed ID: 35361510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
    Veser FH; Veser BD; McMullan JT; Zealberg J; Currier GW
    J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
    Brook S; Walden J; Benattia I; Siu CO; Romano SJ
    Psychopharmacology (Berl); 2005 Apr; 178(4):514-23. PubMed ID: 15650846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
    Bosanac P; Hollander Y; Castle D
    Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study.
    Lin J; Figuerado Y; Montgomery A; Lee J; Cannis M; Norton VC; Calvo R; Sikand H
    Am J Emerg Med; 2021 Jun; 44():306-311. PubMed ID: 32340820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.